Abstract
Background: Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOG-AD) is now recognised as a nosological entity with specific clinical and p......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
